ClearPoint Neuro Q1 FY26 net loss widens to $9.55 million; revenue rises 43% to $12.1 million

ClearPoint Neuro

ClearPoint Neuro

CLPT

0.00
  • ClearPoint Neuro Q1 revenue rose 43% to $12.1 million, including $2.3 million of IRRAflow revenue; total organic growth was 16% year over year.
  • Net loss widened to $9.55 million; loss per share widened to $0.32.
  • Gross margin expanded 4 percentage points to 64%; operating loss widened to $8.48 million.
  • Activated installed base surpassed 175 global centers; Health Canada granted a Medical Device License for ClearPoint Neuro Navigation System, covering MRI-guidance and iCT guidance workflows.
  • Revenue outlook set at $52 million-$56 million for 2026; CEO Joe Burnett said IRRAflow integration should drive “meaningful revenue and cost synergies” in second-half 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ClearPoint Neuro Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605131605ACCESSWRNAPR_____1166597) on May 13, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.